News & Updates
Showing Pharmacy articles
Showing
Show Multimedia Only

Multidrug combos provide optimal glycaemic control in T2D patients
24 Dec 2025
byAudrey Abella
A real-world study from India shows that multiple drug combinations effectively controlled blood sugar levels in individuals with type 2 diabetes (T2D).
Multidrug combos provide optimal glycaemic control in T2D patients
24 Dec 2025
Two DOACs show similar bleeding risks in head-to-head VTE trial
23 Dec 2025
byAudrey Abella
In a post hoc analysis of the RENOVE trial, the direct oral anticoagulants (DOACs) rivaroxaban and apixaban demonstrate comparable risks of clinically relevant bleeding (CRB) and recurrent venous thromboembolism (VTE). These were observed across the crude, adjusted, and IPTW* analyses.







